Ewing Sarcoma: The Pediatrician's Point of View

Pediatric Blood and Cancer

Volumn 42, Issue 5, 2004, Pages 477-480

  Marec Bérard, Perrine ^a   Philip, Thierry ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

Chemotherapy; Ewing sarcoma; Multimodal care

Indexed keywords

BONE CANCER; CANCER CHEMOTHERAPY; CONFERENCE PAPER; DIAGNOSTIC IMAGING; EWING SARCOMA; HUMAN; METASTASIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TREATMENT INDICATION; TUMOR LOCALIZATION;

ALGORITHMS; CHEMOTHERAPY, ADJUVANT; CHILD; COMBINED MODALITY THERAPY; HUMANS; ORTHOPEDIC PROCEDURES; PEDIATRICS; PRACTICE GUIDELINES; RADIOTHERAPY, ADJUVANT; SARCOMA, EWING'S;

EID: 1942454462     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.10473     Document Type: Conference Paper

References (29)

1. Ewing J. Classics in oncology. Diffuse endothelioma of bone. James Ewing. Proceedings of the New York Pathological Society, 1921. CA Cancer J Clin 1972;22:95-98.
2. Price CH, Jeffree GM. Incidence of bone sarcoma in SW England, 1946-1974, in relation to age, sex, tumour site, and histology. Br J Cancer 1977;36:511-522.
3. Turc-Carel C, Philip I, et al. Chromosome study of Ewing's sarcoma (ES) cell lines: Consistency of a reciprocal translocation t(11;22)(q24;q12). Cancer Genet Cytogenet 1984;12:1-19.
4. Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992;359:162-165.
5. De Alava E, Kawai A, Healey JH, et al. EWS-Fli 1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 1998;1:1248-1255.
6. Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing's tumor of bone: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000;18:3108-3114.
7. Rodriguez Galindo C, Spunt SL, Pappo AS. Treatment of Ewing sarcoma family of tumors current status and outlooks for the future. Med Pediatr Oncol 2003;40:276-287.
8. Schleiermacher G, Peter M, Oberlin O, et al. Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized Ewing tumor. J Clin Oncol 2003;21:85-91.
9. Nesbit ME, Jr., Gehan EA, Burgert EO, et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: A long-term follow-up of the First Intergroup study. J Clin Oncol 1990;8:1664-1674.
10. Burgert EO, Jr., Nesbit ME, Garnsey LA, et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: Intergroup study IESS-II. J Clin Oncol 1990;8:1514-1524.
11. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348:694-701.
12. Craft A. Pinkerton Ross, Philip Thierry, fervers Beatrice, editors. Ewing's sarcoma. Evidence-based paediatric oncology 2002. BMJ Books London; 56-71.
13. Pinkerton CR, Bataillard A, Guillo S, et al. Treatment strategies for metastatic Ewing's sarcoma. Eur J Cancer 2001;37:1338-1344.
14. Cangir A, Vietti TJ, Gehan EA, et al. Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 1990;66:887-893.
15. Meyers PA, Krailo MD, Ladanyi M, et al. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol 2001;19:2812-2820.
16. Donaldson SS, Torrey M, Link MP, et al. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: End results of POG #8346. Pediatric Oncology Group. Int J Radiat Oncol Biol Phys 1998;42:125-135.
17. Schuck A, Ahrens S, Paulussen M, et al. Local therapy in localized Ewing tumors: Results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 2003;55:168-177.
18. Carrie C, Mascard E, Gomez F, et al. Nonmetastatic pelvic Ewing's sarcoma: Report of the French society of pediatric oncology. Med Pediatr Oncol 1999;33:444-449.
19. Kuttesch JF, Jr., Wexler LH, Marcus RB, et al. Second malignancies after Ewing's sarcoma: Radiation dose-dependency of secondary sarcomas. J Clin Oncol 1996;14:2818-2825.
20. McLean TW, Hertel C, Young ML, et al. Late events in pediatric patients with Ewing's sarcoma/primitive neuroectodermal tumor of bone: The Dana-Farber Cancer Institute/Children's Hospital experience. J Pediatr Hematol Oncol 1999;21:486-493.
21. Aparicio J, Segura A, Montalar J, et al. Secondary cancers after Ewing's sarcoma and Ewing's sarcoma as second malignant neoplasm. Med Pediatr Oncol 1998;30:259-260.
22. Shapeero LG, Vanel D. Imaging evaluation of the response of high-grade osteosarcoma and Ewing's sarcoma to chemotherapy with emphasis on dynamic contrast-enhanced magnetic resonance imaging. Semin Musculoskelet Radiol 2000;4:137-146.
23. Sluga M, Windhager R, Lang S, et al. The role of surgery and resection margins in the treatment of Ewing's sarcoma. Clin Orthop 2001;392:394-399.
24. Neel MD, Letson GD. Modular endoprostheses for children with malignant bone tumors. Cancer Control 2001;8:344-348.
25. Petite H, Viateau V, Bensaid W, et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000;18:959-963.
26. Tanaka K, Iwakuma T, Harimaya K, et al. EWS-Flil antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J Clin Invest 1997;99:239-247.
27. Kosciolek BA, Kalantidis K, Tabler M, et al. Inhibition of telomerase activity in human cancer cells by RNA interference. Mol Cancer Ther 2003;2:209-216.
28. Sanceau J, Poupon MF, Delattre O, et al. Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide. Oncogene 2002;21:7700-7709.
29. Dagher R, Long LM, Read EJ, et al. Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing's sarcoma and alveolar rhabdomyosarcoma: An inter-institute NIH study. Med Pediatr Oncol 2002;38:158-164.